Helsinki-based Veri said it has raised a $4 million pre-seed and seed round for expansion to the United States and for accelerating growth in Europe.
The investment round in 2020-founded health tech, which has over 50,000 people on its waitlist, was led by PROFounders, accompanied by Lifeline Ventures, Accel and several angel investors, including Johannes Schildt (CEO and cofounder of Kry/Livi), Kristian Ranta (CEO and cofounder of Meru Health) and others.
The combination of Veri’s app with a wearable blood glucose tracker provides real-time feedback on food choices, giving users deep insights by analyzing personalized blood sugar levels in the context of exercise as well as sleep habits.
“Metabolic health is one of the strongest predictors of lifespan. We are on a mission to provide people with an effortless and deeply personalized way of eating, helping everyone reach their health goals and prevent the more distressing diseases.”
Anttoni Aniebonam, CEO and cofounder of Veri
“Veri is one of the most impactful wearable platforms that we have ever seen. It is like having the best nutritionist in the world standing by your side 24-7, helping you understand how your food and lifestyle choices are affecting your personal metabolism in real-time. There aren’t many tools that can drive genuine positive lifestyle change like this, which is what makes this product so incredibly exciting” Dr. Vimal Ramjee, a cardiologist, culinary medicine specialist and the Director of Health at Veri, said in the statement.
